Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL.
Diffuse large B-cell lymphoma and follicular lymphoma exhibit complex metabolic and immune microenvironments that influence disease progression and treatment response.
APA
Chen C, Guo W, et al. (2025). Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL.. Frontiers in immunology, 16, 1659011. https://doi.org/10.3389/fimmu.2025.1659011
MLA
Chen C, et al.. "Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL.." Frontiers in immunology, vol. 16, 2025, pp. 1659011.
PMID
41103431
Abstract
Diffuse large B-cell lymphoma and follicular lymphoma exhibit complex metabolic and immune microenvironments that influence disease progression and treatment response. Metabolic reprogramming, including glycolysis, amino acid, and lipid metabolism, supports tumor growth while suppressing anti-tumor immunity. Immune components such as tumor-infiltrating lymphocytes and checkpoint molecules (PD-L1, LAG-3, TIM-3) further modulate prognosis. Elevated tumor metabolic volume and glycolytic activity correlate with aggressive disease and poor outcomes. Conversely, high TIL density often predicts better responses. Integrating metabolic and immune biomarkers enhances risk stratification and therapeutic strategies, highlighting the potential for combined metabolic inhibitors and immunotherapies to improve precision medicine in lymphoma.
MeSH Terms
Humans; Tumor Microenvironment; Lymphoma, Large B-Cell, Diffuse; Prognosis; Precision Medicine; Lymphocytes, Tumor-Infiltrating; Lymphoma, Follicular; Biomarkers, Tumor; Immunotherapy; Glycolysis
같은 제1저자의 인용 많은 논문 (5)
- Surgical Resection and Reconstruction of Ameloblastoma: A 13-Year Retrospective Review.
- Next-generation sequencing for lymphoid neoplasms: Real-world utility from a clinical assay.
- Wedelolide A induces ferroptosis and apoptosis in gastric cancer via keap1/Nrf2 modulation and ROS generation.
- The pH perspective of cancer: From warburg's misconception to therapeutic targeting of pH regulating proteins.
- Optimizing adjuvant therapy under the guidance of MPR: A multicenter retrospective analysis of neoadjuvant therapy in non-small cell lung cancer.